Overview

11C-acetate for Treatment Response After Radiotherapy for HCC

Status:
Terminated
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
It is thought that PET of the abdomen with 11C Acetate will provide new information regarding whether or not patient's have benefited from radiotherapy. To test this theory, the project will evaluate the potential of 11C acetate to serve as an earlier and/or better signal of treatment success.
Phase:
Phase 2
Details
Lead Sponsor:
Justin Sims